跳至主要内容
临床试验/NCT02330705
NCT02330705Unknown4 期

Timing of Human Chorionic Gonadotropin Administration in Intrauterine Insemination Cycles

Mohamed Ibrahem Eid2 个研究点 分布在 1 个国家目标入组 225 人开始时间: 2015年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
225
试验地点
2
主要终点
Clinical pregnancy rate

研究概览

简要总结

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

详细描述

Women will be randomly divided into 3 groups; the first group will undergo IUI at the time HCG administration, the second group will undergo IUI 12 hours after HCG administration and the third group will undergo IUI 34-36 hours after HCG administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Mild male factor infertility or unexplained infertility.

排除标准

  • Advanced male factor infertility.
  • Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria.
  • Endometriosis.
  • Tubal disease.
  • Uterine abnormalities or myoma.
  • Previous uterine surgery.
  • Metabolic or hormonal abnormalities.

研究组 & 干预措施

Group B

Active Comparator

IUI 12 hours after HCG

干预措施: HCG (Drug)

Group C

Active Comparator

IUI 34-36 hours after HCG

干预措施: HCG (Drug)

Group A

Active Comparator

IUI at time of HCG

干预措施: HCG (Drug)

结局指标

主要结局

Clinical pregnancy rate

时间窗: 4-6 weeks after IUI

Number of clinical pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and cardiac activity on TVS scan at 4-6 weeks after IUI) divided by the number of IUI cycles

次要结局

未报告次要终点

研究者

发起方
Mohamed Ibrahem Eid
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mohamed Ibrahem Eid

Dr

Mansoura University

研究点 (2)

Loading locations...

相似试验

Timing of HCG Administration in IUI Cycles | 临床试验